Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Last revisionBoth sides next revision
home:mp:minocycline [10.25.2018] – [Safety] sallieqhome:mp:minocycline [09.02.2019] – [Minocycline] sallieq
Line 5: Line 5:
 Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and was the base antibiotic of the Marshall Protocol. Minocycline hydrochloride, also known as minocycline, is a broad spectrum tetracycline antibiotic, and was the base antibiotic of the Marshall Protocol.
  
-Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists.+Minocycline is recognized as a DMARD (Disease-Modifying Anti-Rheumatic Drug) by the American College of Rheumatology, which recommends its use as a treatment for mild rheumatoid arthritis.(({{pubmed>long:18512708}})) To minimize its [[home:othertreatments:antibacterials:highdose|dose-dependent immunosuppressive effects]], the Marshall Protocol uses minocycline at pulsed doses [[home:protocol:mp_antibiotics:dosing|much lower]] than otherwise prescribed by rheumatologists.
  
 Either generic or brand name is appropriate to use. Either generic or brand name is appropriate to use.
home/mp/minocycline.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.